Neuropsychopharmacology
- Understanding the emergence of suicidal thoughts and behaviors in adolescence from a brain and behavioral developmental perspective10 months ago
- Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial10 months ago
- Timing matters: modeling the effects of gestational cannabis exposure on social behavior and microglia in the developing amygdala10 months ago
- Estrous cycle stage gates the effect of stress on reward learning11 months ago
- Social Determinants of Health, the developing brain, and risk and resilience for psychopathology11 months ago
- Safety and tolerability of multiple sublingual microdoses of 5-MeO-DMT in adults with moderate symptoms of depression and/or anxiety: a randomized, double-blind, placebo-controlled study11 months ago
- M6A RNA epitranscriptome dynamics linked to major depressive disorder and suicide risk11 months ago
Journal of Psychopharmacology
- Less is more? A review of psilocybin microdosing2 years ago
- The relationship between Parkinson’s disease and sexual hyperactivity secondary to drug treatment: A systematic review2 years ago
- Antipsychotic medication in people with intellectual disability and schizophrenia: A 25-year updated systematic review and cross-sectional study2 years ago
- Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression2 years ago
- Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers2 years ago
- Blackcurrant (Ribes nigrum L.) improves cholinergic signaling and protects against chronic Scopolamine-induced memory impairment in mice2 years ago
- Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis2 years ago
European Neuropsychopharmacology
- Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.2 years ago
- Response to ensuring safety in cannabinoid prescriptions: A call for critical assessment2 years ago
- Clinical research in pediatric autism2 years ago
- From erectile dysfunction to dementia: A new role for sildenafil2 years ago
- The myth of minimum effective dose in antipsychotic treatment for patients with remitted psychosis2 years ago
- Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research2 years ago
- The Transdiagnostic Global Impression – Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice2 years ago